Canopy Growth Corporation
Every calculator, already run for CGC
Open the full toolkit →You have the numbers on CGC. Get the argument.
A written report on which of these readings actually decide the outcome for Canopy Growth Corporation, what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
8 analysts covering CGCOwnership & short interest
Insider Trading Activity for CGC
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Canopy Growth Corporation
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, such as softgel capsules; and cannabis edibles, including gummies. In addition, the company operates e-commerce shop; medical cannabis online distribution platform; and an online medical cannabis clinic. It sells its products under the Tweed, 7ACRES, De…
CGC — frequently asked
Is CGC a buy right now?
Wall Street's consensus rating on Canopy Growth Corporation is none across 8 analysts, with a mean price target of $1.21 (+29% vs. the current $0.94). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is CGC overvalued?
CGC trades at — trailing earnings, against a DCF fair value of $0 per share. The current price implies 25% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is CGC's next earnings date?
Canopy Growth Corporation is next scheduled to report earnings around Nov 6, 2026. A full CGC research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
Compare Canopy Growth Corporation against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Canopy Growth Corporation
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full CGC research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Canopy Growth Corporation, in minutes. 3 free reports included with every account — no credit card required.